GR79383B - - Google Patents

Info

Publication number
GR79383B
GR79383B GR72239A GR830172239A GR79383B GR 79383 B GR79383 B GR 79383B GR 72239 A GR72239 A GR 72239A GR 830172239 A GR830172239 A GR 830172239A GR 79383 B GR79383 B GR 79383B
Authority
GR
Greece
Application number
GR72239A
Other languages
Greek (el)
Original Assignee
Sun Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR79383(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sun Tech Inc filed Critical Sun Tech Inc
Publication of GR79383B publication Critical patent/GR79383B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR72239A 1982-08-17 1983-08-17 GR79383B (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40858982A 1982-08-17 1982-08-17
US51715083A 1983-07-25 1983-07-25

Publications (1)

Publication Number Publication Date
GR79383B true GR79383B (en:Method) 1984-10-22

Family

ID=27020315

Family Applications (1)

Application Number Title Priority Date Filing Date
GR72239A GR79383B (en:Method) 1982-08-17 1983-08-17

Country Status (19)

Country Link
EP (1) EP0105584B1 (en:Method)
JP (1) JPS59501665A (en:Method)
KR (1) KR890002204B1 (en:Method)
AU (1) AU559559B2 (en:Method)
CA (1) CA1225027A (en:Method)
CH (1) CH665952A5 (en:Method)
DE (2) DE3390172T1 (en:Method)
ES (1) ES8502405A1 (en:Method)
FI (1) FI841513L (en:Method)
GB (1) GB2134787A (en:Method)
GR (1) GR79383B (en:Method)
IE (1) IE55618B1 (en:Method)
IL (1) IL69505A (en:Method)
NL (1) NL8320264A (en:Method)
NO (1) NO841519L (en:Method)
PH (2) PH25492A (en:Method)
PT (1) PT77204B (en:Method)
SE (1) SE8402098L (en:Method)
WO (1) WO1984000686A1 (en:Method)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59130812A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
JPS59130813A (ja) * 1983-01-14 1984-07-27 Green Cross Corp:The 癌化学療法補助剤
CA1257828A (en) * 1984-04-16 1989-07-25 William Mccormick Perfluoro compound dispersions containing reduced amounts of surfactant and process of preparation
US4815446A (en) * 1985-05-09 1989-03-28 Alpha Therapeutic Corporation Process for treating metastasis of cancerous tumors
US4781676A (en) * 1987-02-20 1988-11-01 Air Products And Chemicals, Inc. Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells
US4956390A (en) * 1987-08-25 1990-09-11 Air Products And Chemicals, Inc. Gas transport employing perfluorobutyldecalin
US5562608A (en) 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
JP2935519B2 (ja) * 1989-08-28 1999-08-16 シーキンス，ケイ・マイケル 超音波および／またはペルフルオロカーボン液での対流を介する肺癌高熱治療
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US6458376B1 (en) 1990-09-27 2002-10-01 Allergan, Inc. Nonaqueous fluorinated drug delivery suspensions
FR2679150A1 (fr) * 1991-07-17 1993-01-22 Atta Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
WO1993018748A1 (en) * 1992-03-19 1993-09-30 Allergan, Inc. Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
US5643601A (en) * 1992-06-26 1997-07-01 Lancaster Group Ag Phospholipid-and fluorocarbon-containing cosmetic
DE4221268C2 (de) * 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
DE4221256C2 (de) * 1992-06-26 1997-07-10 Lancaster Group Ag Galenische Zusammensetzung für die topische Anwendung
US5480914A (en) * 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
DE69940738D1 (de) * 1998-07-09 2009-05-28 Curelight Medical Ltd Vorrichtung und verfahren zur wirkungsvollen hochenergetischen photodynamischen therapie von akne vulgaris und seborrhoe
US20040122492A1 (en) 1999-07-07 2004-06-24 Yoram Harth Phototherapeutic treatment of skin conditions
GB0200721D0 (en) * 2002-01-14 2002-02-27 Univ Bristol Toxicity test
RU2440158C2 (ru) * 2010-02-25 2012-01-20 Юрий Александрович Белый Способ фотодинамической терапии субъектов, страдающих злокачественными опухолями
EP2587917A4 (en) * 2010-07-01 2015-05-06 Mtm Res Llc FLUORCHEMICAL ANTIFIBROBLAST EMULSION THERAPIES

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828085A (en) * 1970-07-09 1974-08-06 Allied Chem Novel amidoamine oxides
US3823091A (en) * 1971-05-19 1974-07-09 Green Cross Corp Stable emulsion of fluorocarbon particles
US4041086A (en) * 1972-02-07 1977-08-09 Sun Ventures, Inc. Process of manufacture of flourinated alkyladamantanes
US3911138B1 (en) * 1973-02-26 1996-10-29 Childrens Hosp Medical Center Artificial blood and method for supporting oxygen transport in animals
JPS5331209B2 (en:Method) * 1973-10-05 1978-09-01
DE2524363A1 (de) * 1975-06-02 1976-12-16 Boehringer Sohn Ingelheim Neue pharmazeutische mittel
US4105798A (en) * 1976-07-19 1978-08-08 Sun Ventures, Inc. Perfluoro polycyclic compounds for use as synthetic blood and perfusion media
JPS5331209A (en) * 1976-09-03 1978-03-24 Hitachi Ltd Small compressor cylinder for refrigerating machine and production of same
IE47132B1 (en) * 1977-08-19 1983-12-28 Roche Products Ltd Novel nitroimidazoles and pharmaceutical preparations containing these as well as their manufacture
JPS6033367B2 (ja) * 1978-11-24 1985-08-02 株式会社ミドリ十字 酸素運搬輸液
US4282232A (en) * 1979-04-26 1981-08-04 Research Corporation Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
DE3049665T1 (de) * 1979-06-25 1982-03-18 Suntech Use of perfluorocarbon as burn treatment
CA1181011A (en) * 1980-05-27 1985-01-15 Robert P. Geyer Perfluorinated n,n-dimethyl cyclohexylmethylamine and emulsions containing the same
GR78151B (en:Method) * 1982-04-05 1984-09-26 Alcon Lab Inc

Also Published As

Publication number Publication date
PH25027A (en) 1991-01-28
AU559559B2 (en) 1987-03-12
WO1984000686A1 (en) 1984-03-01
ES524972A0 (es) 1985-01-01
FI841513A7 (fi) 1984-04-16
KR890002204B1 (ko) 1989-06-23
GB2134787A (en) 1984-08-22
CA1225027A (en) 1987-08-04
PT77204A (en) 1983-09-01
ES8502405A1 (es) 1985-01-01
SE8402098D0 (sv) 1984-04-16
EP0105584A1 (en) 1984-04-18
NL8320264A (nl) 1984-07-02
DE3390172T1 (de) 1984-11-29
FI841513A0 (fi) 1984-04-16
JPS59501665A (ja) 1984-10-04
NO841519L (no) 1984-04-16
IE831925L (en) 1984-02-17
SE8402098L (sv) 1984-04-16
AU1941383A (en) 1984-03-07
FI841513L (fi) 1984-04-16
EP0105584B1 (en) 1989-01-18
IL69505A0 (en) 1983-11-30
PH25492A (en) 1991-07-24
IL69505A (en) 1990-03-19
CH665952A5 (de) 1988-06-30
PT77204B (en) 1986-02-04
KR840005660A (ko) 1984-11-15
IE55618B1 (en) 1990-11-21
DE3378954D1 (en) 1989-02-23

Similar Documents

Publication Publication Date Title
FR2520390B1 (en:Method)
CH655511B (en:Method)
CH655644B (en:Method)
IN159790B (en:Method)
GR79479B (en:Method)
FR2520076B1 (en:Method)
GR79383B (en:Method)
DE3348365A1 (en:Method)
DE3347867A1 (en:Method)
DE3348339A1 (en:Method)
FR2520314B1 (en:Method)
DE3378493D1 (en:Method)
CH655489B (en:Method)
CH665521GA3 (en:Method)
CH655524B (en:Method)
FR2520133B1 (en:Method)
DK350783D0 (en:Method)
CH655407B (en:Method)
DE3374913T (en:Method)
FR2523036B1 (en:Method)
CH655398B (en:Method)
FR2525816B1 (en:Method)
FR2524028B1 (en:Method)
FR2519894B1 (en:Method)
CH659266B (en:Method)